Kenvue Inc. (NYSE:KVUE) Shares Purchased by Jones Financial Companies Lllp

Jones Financial Companies Lllp grew its holdings in Kenvue Inc. (NYSE:KVUE - Free Report) by 80.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 278,059 shares of the company's stock after acquiring an additional 124,037 shares during the quarter. Jones Financial Companies Lllp's holdings in Kenvue were worth $5,937,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in KVUE. FMR LLC boosted its position in shares of Kenvue by 2.3% in the 3rd quarter. FMR LLC now owns 137,915,493 shares of the company's stock valued at $3,189,985,000 after purchasing an additional 3,075,019 shares during the period. State Street Corp lifted its position in Kenvue by 16.8% during the 3rd quarter. State Street Corp now owns 127,213,940 shares of the company's stock worth $2,942,458,000 after acquiring an additional 18,283,473 shares during the period. Massachusetts Financial Services Co. MA lifted its position in Kenvue by 8.9% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 86,979,341 shares of the company's stock worth $2,011,832,000 after acquiring an additional 7,115,374 shares during the period. Geode Capital Management LLC lifted its position in Kenvue by 0.9% during the 3rd quarter. Geode Capital Management LLC now owns 44,677,077 shares of the company's stock worth $1,029,810,000 after acquiring an additional 399,846 shares during the period. Finally, Harris Associates L P lifted its position in Kenvue by 7.5% during the 3rd quarter. Harris Associates L P now owns 31,459,511 shares of the company's stock worth $727,658,000 after acquiring an additional 2,186,114 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on KVUE. Deutsche Bank Aktiengesellschaft cut Kenvue from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $25.00 to $24.00 in a research report on Thursday, December 12th. Barclays decreased their price target on Kenvue from $23.00 to $21.00 and set an "equal weight" rating on the stock in a research note on Friday, January 17th. Piper Sandler lifted their price target on Kenvue from $24.00 to $27.00 and gave the company an "overweight" rating in a research note on Monday, February 24th. UBS Group decreased their target price on Kenvue from $23.00 to $21.00 and set a "neutral" rating on the stock in a research report on Friday, February 7th. Finally, Royal Bank of Canada reiterated a "sector perform" rating and set a $24.00 target price on shares of Kenvue in a research report on Monday, February 3rd. One analyst has rated the stock with a sell rating, seven have given a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $23.75.

Kenvue Price Performance

Shares of NYSE KVUE traded down $0.38 during trading on Wednesday, reaching $23.05. The company had a trading volume of 17,384,447 shares, compared to its average volume of 14,670,809. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $24.46. The stock has a market capitalization of $44.04 billion, a PE ratio of 43.48, a price-to-earnings-growth ratio of 2.62 and a beta of 1.45. The stock has a 50-day moving average price of $21.54 and a two-hundred day moving average price of $22.30. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, hitting analysts' consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. As a group, sell-side analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th were issued a $0.205 dividend. The ex-dividend date of this dividend was Wednesday, February 12th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.56%. Kenvue's dividend payout ratio (DPR) is 154.72%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.